Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biogen Inc (NASDAQ:BIIB)

Friday’s trading has closed, but BIIB is being traded in the after-hours session. After-Hours quote »
318.78
Delayed Data
As of 3:59pm ET
 +1.78 / +0.56%
Today’s Change
290.85
Today|||52-Week Range
480.18
-6.09%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Rowinsky Eric K
Director
Sale3/20/201511,667$475.00$5.5M-33.40%
Cox John G
EVP-Pharmaceutical Operations & Technology
Sale3/25/201512,010$449.06$5.4M-26.56%
Scangos George A
Chief Executive Officer
Sale2/10/20158,871$395.13$3.5M-19.77%
Sherwin Stephen A
Director
Sale3/10/20156,000$409.67$2.5M-23.47%
Rowinsky Eric K
Director
Sale3/17/20154,667$425.45$2.0M-25.61%
Scangos George A
Chief Executive Officer
Sale2/09/20154,940$396.88$2.0M-20.13%
Rowinsky Eric K
Director
Sale3/09/20154,666$417.23$1.9M-23.71%
Scangos George A
Chief Executive Officer
Sale2/12/20154,781$392.11$1.9M-19.16%
Scangos George A
Chief Executive Officer
Sale2/12/20154,329$392.11$1.7M-19.16%
Williams Douglas E
Executive VP-Research & Development
Sale6/19/20153,841$410.00$1.6M-22.88%
Page of 17